 |
valsartan oral solution |
|---|---|
| Trade Name | |
| Orphan Indication | Hypertension in pediatric patients 0 through 16 years of age |
| USA Market Approval | USA |
| USA Designation Date | 2015-10-28 00:00:00 |
| Sponsor | Carmel Biosciences;5673 Peachtree Dunwoody Road, Suite 440;Atlanta, Georgia, 30342 |
